• Je něco špatně v tomto záznamu ?

Phage therapy of wound-associated infections

A. Zyman, A. Górski, R. Międzybrodzki

. 2022 ; 67 (2) : 193-201. [pub] 20220113

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22013093

Phages are viruses which can specifically infect bacteria, resulting in their destruction. Bacterial infections are a common complication of wound healing, and experimental evidence from animal models demonstrates promising potential for phage-dependent eradication of wound-associated infections. The studies discussed suggest that phage therapy may be an effective treatment, with important advantages over some current antibacterial treatments. Phage cocktails, as well as co-administration of phages and antibiotics, have been reported to minimise bacterial resistance. Further, phage-antibiotic synergism has been reported in some studies. The ideal dose of phages is still subject to debate, with evidence for both high and low doses to yield therapeutic effects. Novel delivery methods, such as hydrogels, are being explored for their advantages in topical wound healing. There are more and more Good Manufacturing Practice facilities dedicated to manufacturing phage products and phage therapy units across the world, showing the changing perception of phages which is occurring. However, further research is needed to secure the place of phages in modern medicine, with some scientists calling upon the World Health Organisation to help promote phage therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22013093
003      
CZ-PrNML
005      
20240416145021.0
007      
ta
008      
220504s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-021-00946-1 $2 doi
035    __
$a (PubMed)35028881
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zyman, Anna $u Pharmacology Undergraduate Programme, School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, University Walk, Bristol, BS8 1TD, UK
245    10
$a Phage therapy of wound-associated infections / $c A. Zyman, A. Górski, R. Międzybrodzki
520    9_
$a Phages are viruses which can specifically infect bacteria, resulting in their destruction. Bacterial infections are a common complication of wound healing, and experimental evidence from animal models demonstrates promising potential for phage-dependent eradication of wound-associated infections. The studies discussed suggest that phage therapy may be an effective treatment, with important advantages over some current antibacterial treatments. Phage cocktails, as well as co-administration of phages and antibiotics, have been reported to minimise bacterial resistance. Further, phage-antibiotic synergism has been reported in some studies. The ideal dose of phages is still subject to debate, with evidence for both high and low doses to yield therapeutic effects. Novel delivery methods, such as hydrogels, are being explored for their advantages in topical wound healing. There are more and more Good Manufacturing Practice facilities dedicated to manufacturing phage products and phage therapy units across the world, showing the changing perception of phages which is occurring. However, further research is needed to secure the place of phages in modern medicine, with some scientists calling upon the World Health Organisation to help promote phage therapy.
650    _2
$a zvířata $7 D000818
650    _2
$a antibakteriální látky $x terapeutické užití $7 D000900
650    _2
$a Bacteria $7 D001419
650    12
$a bakteriální infekce $x terapie $7 D001424
650    12
$a bakteriofágy $7 D001435
650    12
$a fágová terapie $x metody $7 D000071059
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Górski, Andrzej $u Bacteriophage Laboratory, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wrocław, Poland. andrzej.gorski@hirszfeld.pl $u Phage Therapy Unit, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wrocław, Poland. andrzej.gorski@hirszfeld.pl $u Infant Jesus Hospital, Medical University of Warsaw, 02-005, Warsaw, Poland. andrzej.gorski@hirszfeld.pl $1 https://orcid.org/0000000208636041
700    1_
$a Międzybrodzki, Ryszard $u Bacteriophage Laboratory, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wrocław, Poland $u Phage Therapy Unit, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wrocław, Poland $u Department of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, 02-006, Warsaw, Poland $1 https://orcid.org/0000000173797290
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 67, č. 2 (2022), s. 193-201
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35028881 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220504 $b ABA008
991    __
$a 20240416145018 $b ABA008
999    __
$a ok $b bmc $g 1796131 $s 1164301
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 67 $c 2 $d 193-201 $e 20220113 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
LZP    __
$a Pubmed-20220504

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...